Skip Nav Destination

Issue Archive

Select Year

Issue

Volume 19, Issue 5

September-October 2022

In this Issue

Clinical Trials Corner
Diffusion
Feature
Headlines from Washington
Image Challenge
Letter to the Editor
Mini Review
President’s Column

Clinical Trials Corner

Menin Inhibitors: A Promising Class of Targeted Therapies for KMT2A-rearranged and NPM1-mutated Acute Leukemias

Christine M. McMahon, MD

View Articletitled, Menin Inhibitors: A Promising Class of Targeted Therapies for KMT2A-rearranged and NPM1-mutated Acute Leukemias

Toward Optimizing the Microbiome for Transplant Patients

Kate A Markey, MBBS, PhD

View Articletitled, Toward Optimizing the Microbiome for Transplant Patients

Diffusion

Another Phase III Trial Confirms That the Standard of Care Is Difficult to Beat When It Comes to Allogeneic Hematopoietic Cell Transplantation

Lori Muffly, MD, MS

View Articletitled, Another Phase III Trial Confirms That the Standard of Care Is Difficult to Beat When It Comes to Allogeneic Hematopoietic Cell Transplantation

Iatrogenic Bleeding Disorders: AFIRE That Requires Your Attention

Damon Houghton, MD,Waldemar Wysokinski, MD, PhD

View Articletitled, Iatrogenic Bleeding Disorders: AFIRE That Requires Your Attention

Is There Still Equi-POISE for the Use of Tranexamic Acid for Non-cardiac Surgery?

Eric Tseng, MD, MScCH, FRCPC

View Articletitled, Is There Still Equi-POISE for the Use of Tranexamic Acid for Non-cardiac Surgery?

Iron-restricted Erythropoiesis in Sickle Cell Disease

David C. Rees, MA, MBBS

View Articletitled, Iron-restricted Erythropoiesis in Sickle Cell Disease

Shining a Light on a Randomized Trial: Ibrutinib Plus Rituximab and Bendamustine in Untreated Mantle Cell Lymphoma

Loretta J. Nastoupil, MD

View Articletitled, Shining a Light on a Randomized Trial: Ibrutinib Plus Rituximab and Bendamustine in Untreated Mantle Cell Lymphoma

Stem Cells and Stealth Immunosurveillance

Bethan Psaila, MD, PhD

View Articletitled, Stem Cells and Stealth Immunosurveillance

IPSS-M Incorporates Next-Generation Sequencing for a New International Prognostic Scoring System

Robert P. Hasserjian, MD

View Articletitled, IPSS-M Incorporates Next-Generation Sequencing for a New International Prognostic Scoring System

High-Dose Melphalan Is the Tom Brady of the Myeloma World

Binod Dhakal, MD,Saad Z. Usmani, MD, MBA, FACP

View Articletitled, High-Dose Melphalan Is the Tom Brady of the Myeloma World

CDX2/UBTF Acute Lymphoblastic Leukemia: Subtype Discovery and Clinical Implications

Kristen M. O’Dwyer, MD

View Articletitled, CDX2/UBTF Acute Lymphoblastic Leukemia: Subtype Discovery and Clinical Implications

Feature

How the NIDDK Cooperative Centers of Excellence in Hematology Can Help With Your Research

Shilpa Hattangadi, MD

View Articletitled, How the NIDDK Cooperative Centers of Excellence in Hematology Can Help With Your Research

Open the PDF for in another window

Communication and Relationships Are Key When It Comes to HCT

Heather Stefanski, MD, PhD,Courtney Bellomo, MD

View Articletitled, Communication and Relationships Are Key When It Comes to HCT

Headlines from Washington

Congress Continues Work on FY 2023 Appropriations Process

View Articletitled, Congress Continues Work on FY 2023 Appropriations Process

Image Challenge

Interesting Bone Marrow Finding in a Patient With Splenomegaly

Juliana Perez Botero, MD,Maria E. Hintzke, MD

View Articletitled, Interesting Bone Marrow Finding in a Patient With Splenomegaly

Letter to the Editor

In Response to Lymphohematopoietic Clones

David P. Steensma, MD,Rafael Bejar, MD, PhD,Siddhartha Jaiswal, MD, PhD,Mikkael A. Sekeres, MD,Robert P. Hasserjian, MD,Benjamin L. Ebert, MD, PhD

View Articletitled, In Response to Lymphohematopoietic Clones

Mini Review

The Ups and Downs of Leukemia in Children With Trisomy 21

Kaoru Takasaki, MD,Sarah K Tasian, MD

View Articletitled, The Ups and Downs of Leukemia in Children With Trisomy 21

President’s Column

Unintended Consequences: ASH’s Advocacy for Maternal Health After the Dobbs Decision

Jane N. Winter, MD

View Articletitled, Unintended Consequences: ASH’s Advocacy for Maternal Health After the Dobbs Decision

Cover Image

Cover Image

All Issues

Email alerts

Latest Issue Alert

Continuous Publishing Alert

New Journal Content Alert

Latest
Most Read

Sequencing of Therapy Matters in the Era of Autologous Chimeric Antigen Receptor T-cell Therapy

Restoring T-cell Cytotoxicity To Correct Familial Hemophagocytic Lymphohistiocytosis

Not So Benign
This Is Not Your Father’s Thrombotic Thrombocytopenic Purpura

Perspective
Procedure Skills in Hematology Training: Lost Cause or Worth Fighting For?

ASH Committees Visit Capitol Hill in Support of Funding

Table of Contents

Clinical Trials Corner

Menin Inhibitors: A Promising Class of Targeted Therapies for KMT2A-rearranged and NPM1-mutated Acute Leukemias

Toward Optimizing the Microbiome for Transplant Patients

Diffusion

Another Phase III Trial Confirms That the Standard of Care Is Difficult to Beat When It Comes to Allogeneic Hematopoietic Cell Transplantation

Iatrogenic Bleeding Disorders: AFIRE That Requires Your Attention

Is There Still Equi-POISE for the Use of Tranexamic Acid for Non-cardiac Surgery?

Iron-restricted Erythropoiesis in Sickle Cell Disease

Shining a Light on a Randomized Trial: Ibrutinib Plus Rituximab and Bendamustine in Untreated Mantle Cell Lymphoma

Stem Cells and Stealth Immunosurveillance

IPSS-M Incorporates Next-Generation Sequencing for a New International Prognostic Scoring System

High-Dose Melphalan Is the Tom Brady of the Myeloma World

CDX2/UBTF Acute Lymphoblastic Leukemia: Subtype Discovery and Clinical Implications

Feature

How the NIDDK Cooperative Centers of Excellence in Hematology Can Help With Your Research

Communication and Relationships Are Key When It Comes to HCT

Headlines from Washington

Congress Continues Work on FY 2023 Appropriations Process

Image Challenge

Interesting Bone Marrow Finding in a Patient With Splenomegaly

Letter to the Editor

In Response to Lymphohematopoietic Clones

Mini Review

The Ups and Downs of Leukemia in Children With Trisomy 21

President’s Column

Unintended Consequences: ASH’s Advocacy for Maternal Health After the Dobbs Decision

Email alerts

ASH Publications

American Society of Hematology

Issue Archive

Table of Contents

Clinical Trials Corner

Diffusion

Feature

Headlines from Washington

Image Challenge

Letter to the Editor

Mini Review

President’s Column

Cover Image

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only